Robotic Prostate Surgery Explained
Robotic prostate surgery usually refers to robot-assisted radical prostatectomy for localized or selected locally advanced prostate cancer. Through several small abdominal ports, the surgeon controls articulated instruments and a magnified three-dimensional camera from a console. The robot does not make decisions or perform the operation independently. Compared with open surgery, robotic prostatectomy generally reduces blood loss and can shorten early recovery, but it does not remove the core risks of prostatectomy: urinary leakage, erectile dysfunction and cancer recurrence. Long-term outcomes depend strongly on cancer biology, case selection and the surgeon’s technique and experience.
What happens during robotic prostatectomy?
- General anaesthesia is given and ports are placed through the abdominal wall.
- The prostate and seminal vesicles are carefully separated from surrounding structures.
- The surgeon preserves the neurovascular bundles when it is oncologically safe to do so.
- Pelvic lymph nodes are removed when indicated by risk assessment.
- The prostate specimen is removed through one of the port sites.
- The bladder is reconnected to the urethra and a urinary catheter is left while the join heals.
What are the advantages of the robotic approach?
- Magnified high-definition view of deep pelvic anatomy.
- Wristed instruments with fine movement in a confined space.
- Usually lower blood loss than open surgery.
- Smaller skin incisions and often quicker early mobilization.
- Short hospital stay in many centres.
These are procedural advantages. They do not guarantee better cancer cure, continence or erectile recovery for every patient.
What the robot cannot guarantee
| Claim | Reality |
|---|---|
| “No incontinence” | Leakage is common early after any radical prostatectomy and recovery varies. |
| “No erectile dysfunction” | Nerves can still be stretched, bruised or removed for cancer clearance. |
| “No cancer recurrence” | Recurrence depends on tumour grade, stage, margins, nodes and biology. |
| “No scar” | There are several small port scars plus a slightly larger extraction site. |
| “The robot is more experienced than the surgeon” | The surgeon controls every instrument movement; robotic technology amplifies technique rather than replacing expertise. |
Nerve-sparing during robotic surgery
The magnified view can help precise dissection, but nerve-sparing depends mainly on whether cancer can be removed safely. MRI location, biopsy grade and side-specific tumour risk are considered. In higher-risk tumours, wider excision may be necessary even if it reduces erectile-function recovery.
Recovery timeline
Walking usually begins the same day or next day. The catheter commonly remains about 1–2 weeks. Light activity increases gradually, while heavy lifting and strenuous exercise are avoided for several weeks. Return to desk work may be possible within a few weeks, but fatigue and continence needs often determine practical timing.
Pelvic-floor exercises are usually started or resumed according to the surgical team’s instructions. Erectile rehabilitation may begin after catheter removal or early in recovery depending on the plan.
Who may not be an ideal robotic candidate?
Most men who are surgical candidates can be considered for robotic surgery, but previous extensive abdominal/pelvic surgery, severe cardiopulmonary limitations related to steep Trendelenburg positioning, unusual anatomy or lack of appropriate expertise can influence approach. Open surgery remains a valid cancer operation when it is better suited to the patient or surgeon.
How should you compare surgeons or centres?
- Ask about experience with your risk category, not only total robotic case numbers.
- Ask how positive margins, continence and complications are audited.
- Ask how nerve-sparing decisions are made.
- Ask who manages persistent incontinence or erectile dysfunction after surgery.
- Ask whether pathology and imaging are reviewed in a multidisciplinary setting for higher-risk disease.
What robotic surgery changes — and what it does not
The robot provides a magnified three-dimensional view, articulated instruments and stable fine movement through small ports. It does not operate autonomously: every instrument movement is controlled by the surgeon. These features can reduce blood loss and make precise pelvic dissection easier, but they do not remove the biological risks of prostatectomy. Urine leakage, erectile dysfunction, positive margins and complications remain influenced by tumour extent, anatomy, baseline function and surgical technique.
For a patient choosing a centre, the relevant question is not simply whether a robot is available. Ask how often the team performs radical prostatectomy, how complications are managed, how continence and sexual outcomes are tracked, and what happens if the cancer is found to extend beyond the expected plane. Experience and a reliable peri-operative system matter as much as the platform.
Questions worth asking about a robotic programme
- How many radical prostatectomies does the surgeon and team perform regularly?
- How are continence and erectile outcomes measured — and at what time point?
- How often is nerve-sparing attempted, and when is it deliberately avoided for cancer control?
- Who manages complications, catheter problems and postoperative readmissions?
- How is final pathology reviewed and how is early salvage radiotherapy coordinated if PSA does not behave as expected?
These questions are more informative than asking whether the operation is “robotic” in isolation. A robot is a surgical platform; outcomes still depend on judgement, technique and the entire peri-operative system.
When to seek urgent medical care
After prostatectomy, contact the surgical team urgently for a catheter that stops draining with increasing lower-abdominal pain, fever, heavy bleeding or clots, persistent vomiting, worsening abdominal swelling, new calf swelling, chest pain or breathlessness.
Consultation checklist
- Biopsy report and Grade Group.
- Prostate MRI and staging scans.
- PSA history.
- Baseline continence and erectile function.
- Previous abdominal/pelvic operations.
- Cardiac and lung history relevant to general anaesthesia.
- Blood thinners and regular medicines.
FAQs
Is robotic prostatectomy better than open prostatectomy?
Robotic surgery usually offers less blood loss and smaller incisions, but high-quality open surgery remains effective. Long-term cancer and functional outcomes depend heavily on surgeon experience and patient/tumour factors.
How many cuts are made?
Typically several small port incisions are used, with one enlarged enough to remove the prostate specimen. Exact placement varies.
Can I go home the next day?
Many patients can, but discharge depends on pain control, mobility, medical fitness and centre protocol.
Does robotic surgery mean I will recover erections faster?
Not necessarily. Erectile recovery depends more on age, baseline function, nerve-sparing and vascular health than on the presence of a robot.
Can high-risk prostate cancer be treated robotically?
Selected high-risk cancers can be treated with robotic radical prostatectomy as part of a multimodal strategy, but staging and the likelihood of needing additional treatment should be discussed beforehand.
Related reading
- Radical Prostatectomy Explained
- Radiation vs Surgery for Prostate Cancer
- Urine Leakage After Prostate Cancer Surgery
- Erectile Dysfunction After Prostate Cancer Treatment
- PSA After Prostate Cancer Treatment
- Robotic Partial Nephrectomy Explained
- Urologist in Latur
References
- European Association of Urology (EAU). EAU Guidelines on Prostate Cancer. 2026 edition https://uroweb.org/guidelines/prostate-cancer
- British Association of Urological Surgeons (BAUS). Radical prostatectomy patient information https://www.baus.org.uk/
- National Cancer Institute. Prostate Cancer Treatment (PDQ®)–Patient Version https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq
- American Urological Association/ASTRO. Clinically Localized Prostate Cancer Guideline (2022; amended 2026) https://www.auanet.org/guidelines-and-quality/guidelines/clinically-localized-prostate-cancer-aua/astro-guideline-2022